Hyperice Unveils Next Generation of Contrast Therapy Innovation, Hyperice X 2 Knee and Hyperice X 2 Shoulder
19.8.2025 15:00:00 CEST | Business Wire | Press Release
Hyperice, a global high-performance wellness brand, today announced the global launch of Hyperice X 2, the next generation of its best-selling Hyperice X contrast therapy line. Born from the acquisition of RecoverX in 2021 and refined through athlete testing, Hyperice X 2 is the most advanced portable contrast therapy device on the market. The Hyperice X 2 Knee and Hyperice X 2 Shoulder feature major upgrades from their predecessor devices, including deeper cold, stronger heat, and a built-in compression system to aid athletes and active users with more effective warm-up and recovery strategies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250819036830/en/
Driven by athlete feedback, the new Hyperice X 2 unlocks a new era of contrast recovery tech with powerful multi-level compression. With advanced technology tested and proven by athletes, Hyperice X 2 Knee and Hyperice X 2 Shoulder bring elite-level warm-up and recovery contrast therapy solutions in a new, user-friendly device designed for everyday use.
Hyperice X 2 marks the most substantial evolution in technology from its first-generation product. The breakthrough innovation was built and refined through a rigorous feedback loop with elite athletes. Every detail, from contrast and compression ranges to fit and portability, has been accounted for, ensuring the product meets the demands of elite athletes on the sideline alongside everyday individuals.
“Recovery and wellness are fundamental to living well, from professional athletes to people of all ages,” said Jim Huether, CEO of Hyperice. “Our mission is to provide the most advanced and effective solutions to help people move, feel, and perform better every day. With Hyperice X 2 Shoulder and Hyperice X 2 Knee, we’re not just advancing recovery, we’re redefining it. This next generation maintains the mobility and power of its predecessor while seamlessly fusing contrast therapy and compression into a sleek, more practical design.”
With advanced technology tested and proven by athletes, Hyperice X 2 Knee and Hyperice X 2 Shoulder bring elite-level warm-up and recovery contrast therapy solutions in a new, user-friendly device designed for everyday use. Whether training, rehabbing from injury or surgery, or staying active on the go, users can prime their bodies, recover faster, and perform at their best.
Key Features:
- Addition of compression: Five levels of compression (up to 160mmHg) push temperatures deeper into the tissue, allowing users to tailor the compression to their needs and achieve a more customized fit.
- Targeted contrast therapy: Expanded temperature ranges now span from 40°F (4°C) to 121°F (49°C), with five levels of cooling and five levels of heating, to ease inflammation and boost circulation as needed. Up from the original Hyperice X range at 45°F (7°C) to 113°F (45°C).
- Smart control and all-in-one mobility: A new all-in-one OLED display allows seamless switching between hot, cold, and contrast therapy, as well as select compression levels. Hyperice X 2 is cord-free for use on the move, with an option to plug in to the wall for extended rehab sessions.
- Manual and Bluetooth compatibility: New to Hyperice X 2, users can use the device with or without Bluetooth connectivity to the Hyperice app, allowing pros to leverage the technology on the sidelines easier than ever before.
- Extended battery life: Up to 1.5 hours of continuous portable use (1 hour on max cold, 1 hour on max contrast, and 1.5 hours on max heat) - 34% more capacity compared to the original Hyperice X line.
- Lightweight and portable: Just 2.5 lbs and TSA-friendly, Hyperice X 2 Knee and Hyperice X 2 Shoulder prioritize portability and ease of use. Each device is designed to fit both the right and left sides, to allow for increased versatility and on-the-go therapy.
From Generation 1 to Game-Changer
Building on the success of the original Hyperice X Knee and Hyperice X Shoulder models, Hyperice X 2 uses thermoelectric systems to deliver instant heat and cold temperatures on demand, without the need for ice or liquid. Hyperice X 2 introduces a clinically inspired multi-level compression system that drives temperatures deeper into tissue, ultra-convenient on-device smart controls, and cord-free portability. Now, this athlete-endorsed technology comes in a lightweight, portable device designed to help anyone, anytime, anywhere.
“I’ve put everything into this off-season to come back stronger, and recovery is where that work pays off with the Hyperice X 2 Shoulder playing a major role in my routine,” said Jayden Daniels, Washington Commanders quarterback and Hyperice athlete. “I can push my limits on the field because the built-in compression elevates my warm-up, and the contrast therapy helps me bounce back quickly for peak performance.”
Benefits of contrast therapy include:
- Reduces swelling and pain: Contrast moves fluid, while compression limits buildup to ease inflammation and discomfort.
- Relaxes muscles and boosts circulation: Heat loosens tight muscles, cold calms spasms, and both, paired with compression, improve blood flow.
- Improves range of motion: Reduces stiffness, mobilizes joints, and softens tissue for smoother, safer movement.
- Flushes waste: Contrast and compression work together to speed up the removal of lactic acid and other byproducts.
- Aids warm-up and recovery: Increases tissue readiness before activity and helps muscles reset and recover after.
The Hyperice X 2 Knee and Hyperice X 2 Shoulder are available now in the U.S. at hyperice.com, Best Buy, Dick’s Sporting Goods, and REI for $449. In Europe and the UK, the same cutting-edge technology will be available at hyperice.com as Hyperice Contrast 2 on September 15, retailing for £399 or €449.
Assets can be found HERE.
About Hyperice
Hyperice is a technology-driven company with a giant mission, to help everyone on Earth move and live better. For more than a decade, Hyperice has led a global movement at the confluence of recovery and wellness, specializing in percussion (Hypervolt line), dynamic air compression (Normatec line), vibration (Vyper and Hypersphere lines), thermal technology (Venom line), contrast therapy (Hyperice X), and Hyperboot collaboration with Nike. Now, as a holistic high-performance wellness brand, Hyperice is designed for all - from the most elite athletes, leagues, and teams to consumers everywhere looking to unlock the best version of themselves to help them do what they love, more. Recognized as one of Fast Company’s Most Innovative Companies and a TIME Best Inventions winner, Hyperice has applied its technology and know-how to industries including fitness, hospitality, healthcare, massage, physical therapy, sports performance, and workplace wellness on a global scale. For more information, visit hyperice.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250819036830/en/
Contacts
MEDIA CONTACT:
Will McClaran
Jack Taylor PR
hyperice@jacktaylorpr.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma’s Relfydess™ (relabotulinumtoxinA) Receives Approval in China for Frown Lines23.10.2026 07:00:00 CEST | Press Release
Galderma (SIX: GALD) today announced that the Chinese NMPA has approved Relfydess for the temporary improvement of moderate-to-severe frown lines in adults, marking a significant expansion of the company’s Injectable Aesthetics portfolio in China – one of the world's largest and fastest-growing aesthetics markets.8,9 This approval follows successful authorizations and launches of Relfydess in more than 35 markets worldwide. Relfydess is the first and only ready-to-use liquid neuromodulator developed with PEARL Technology, designed to deliver a highly active, innovative, complex-free molecule that addresses the real needs of patients and healthcare professionals.1,2,4,5 It is optimized for simple volumetric dosing, without reconstitution, to increase ease-of-use and help ensure consistent dose/volume every time.1,10 At a time whenpatients and healthcare professionals are increasingly seeking high-performance neuromodulators that rapidly deliver long-lasting, natural-looking outcomes, Re
Mundipharma Announces Further Phase III ReSPECT Results Presented as a Late-Breaking Oral Presentation at IDWeek 202622.10.2026 19:03:00 CEST | Press Release
Today Mundipharma announced additional results from the global Phase III ReSPECT clinical trial evaluating REZZAYO®(rezafungin acetate) for prophylaxis of invasive fungal diseases (IFDs) in adult patients undergoing allogeneic haematopoietic stem cell transplantation (allo-HSCT). The Phase III findings were presented today as a late-breaking oral presentation at IDWeek 2026. The presentation provides additional detail following the top line ReSPECT results announced in April 2026, including further endpoint analyses, the components contributing to fungal-free survival (FFS), pre-specified sensitivity analyses and detailed safety outcomes. The additional analyses were consistent with the previously announced topline findings. ReSPECT was a global, multicentre, randomised, double-blind Phase III study in which 402 patients were randomised to rezafungin and 200 to the standard antimicrobial regimen. As previously announced, the study met its primary endpoint, demonstrating non-inferiority
Tigo Energy Improves Installer Choice via Fronius Compatibility with TS4 Product Line22.10.2026 18:02:00 CEST | Press Release
Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy software solutions, today announced a manufacturer declaration of compatibility from Fronius International GmbH, documenting compatibility between Tigo Flex MLPE products and multiple Fronius inverter families. The letter covers Tigo TS4-A-F, TS4-A-2F, TS4-A-O, and TS4-X-O products and the Fronius Primo GEN24, Primo GEN24 208-240, Symo GEN24, Verto, Tauro, and Tauro ECO inverter families, when configured according to the requirements specified by Fronius and Tigo. Building on established compatibility in Europe, the declaration extends manufacturer-confirmed compatibility to markets worldwide, including the United States and Canada, giving solar professionals greater flexibility to design high-quality systems using manufacturer-confirmed technology combinations. Fronius develops solar technologies and solutions for residential, commercial, and large-scale applications, with a port
Saudi Maritime & Logistics Congress Highlights Maritime Sector Integration and Opportunities for Trade and Investment Growth in the Kingdom22.10.2026 16:52:00 CEST | Press Release
The Saudi Maritime & Logistics Congress highlighted Saudi Arabia’s role in supporting the continuity of trade flows and strengthening supply chain resilience as it opened at Jeddah Superdome, bringing together representatives of government entities, maritime transport and logistics leaders, and the business community. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022362613/en/ The Congress takes place as rapid changes in trade and shipping prompt companies to reassess transport routes and operational and investment choices. It provides a platform for dialogue among stakeholders to explore opportunities for cooperation and strengthen integration between ports and maritime, land transport and logistics services, supporting operational efficiency and supply chain reliability. In his opening address, His Excellency Eng. Fawaz Alsahli, President of the Transport General Authority in Saudi Arabia, emphasised that the Kingdom’s
Ministerial Roundtable Discusses Mobilising Green Investments for a Resilient and Inclusive Global Economy22.10.2026 16:49:00 CEST | Press Release
HE Saeed Mohammed Al Tayer, Chairman of the World Green Economy Organization, opened the Ministerial Roundtable titled "From Ambition to Bankable Action-Mobilising Green Investments for a Resilient and Inclusive Global Economy," during the 12th World Green Economy Summit (WGES), held on 21-22 October 2026 at the Dubai World Trade Centre under the theme "From Success to Scale: Showcasing the Green Economy." This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022803264/en/ Ministerial Roundtable Discusses Mobilising Green Investments for a Resilient and Inclusive Global Economy (Photo: AETOSWire) The session was attended by HE Dr. Amna bint Abdullah Al Dahak, Minister of Climate Change and Environment, the United Arab Emirates; HE Aliou Gori Diouf, Minister of Environment and Ecological Transition, Senegal; HE Balarabe Abbas Lawal, Minister of Environment, Nigeria; HE Steven Victor, Minister of Agriculture, Fisheries, and the En
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom